Testing a new filter to prevent stroke during heart valve replacement
Part of Heart & circulation clinical trials.
This trial tests a new filter device designed to catch debris that might travel to the brain during a minimally invasive aortic valve replacement (TAVR). The goal is to see if it can help reduce the risk of stroke.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 50 years old or older.
- You are scheduled to have a TAVR (aortic valve replacement through a leg artery).
- You are able and willing to follow up with the study team after the procedure.
- You meet the criteria to use the standard filter device (Sentinel).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new device called ShortCut to help doctors safely replace a failing bioprosthetic heart valve (a valve that was placed in your heart previously) using a minimally invasive procedure. The ShortCut is designed to protect your coronary arteries—the vessels that supply blood to your heart—during this valve replacement.
This study tests if a special device placed during transcatheter aortic valve replacement (TAVR) can help prevent stroke. It is for adults with severe aortic stenosis who are already scheduled for TAVR.
This trial studies a new balloon used during a TAVI procedure to replace your aortic valve without open-heart surgery. It aims to see if the balloon is safe and works well for people with severe aortic stenosis.
This early feasibility study tests a device filter system used during a TAVR procedure to help protect the brain and other organs from debris that can break free. It looks mainly at whether the filter can be safely placed and delivered as planned.
This trial is testing a new device called POINT-GUARD that is used during TAVR (a procedure to replace a heart valve). It aims to see if the device can safely catch any debris or particles that might travel to the brain during the procedure.
This trial studies a device and a technique meant to capture debris during a repeat aortic valve procedure (valve-in-valve TAVR). It may help doctors understand if the approach reduces risk from material that can break loose during the procedure.
Hear when a new Aortic Stenosis Treated With TAVI trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.